Dr Sean Bennett | Director of Senior Clinical Development and Medical Affairs
PaxVax Inc

Dr Sean Bennett, Director of Senior Clinical Development and Medical Affairs, PaxVax Inc

Dr Bennett joined PaxVax in 2016 to lead clinical development activities across its portfolio of vaccines.  Prior to joining PaxVax, Dr Bennett led the pediatric antiretroviral development team at Gilead.  His previous vaccine development experience includes evaluation of novel adjuvants for vaccines and immunotherapeutics against tuberculosis, hepatitis B, and HIV.  Dr Bennett received his MD and PhD (Immunology) degrees from the University of Colorado and trained in pediatrics at Dartmouth.


Agenda Day 2 @ 2:45

Development of a correlate of protection for a live oral cholera vaccine

  • Review of the immune response to cholera
  • Protective efficacy in a human challenge model
  • Establishment of a correlate for use in pre-licensure studies
  • Extension of this approach for post-approval studies

back to speakers